Terns Pharmaceuticals

Terns Pharmaceuticals

Biotechnology Research 1065 E Hillsdale Blvd 60 employees
Employees
60
Contacts
2
Emails
2
Phones
1

Terns Pharmaceuticals Overview

Headquarters
1065 E Hillsdale Blvd
Website
ternspharma.com
Industry
Biotechnology Research
Employees
60
Founded
2017
Funding
150.2M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Terns Pharmaceuticals

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated otherwise.

Terns Pharmaceuticals Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

Terns Pharmaceuticals Org Chart

Sample employees and titles
Name Title Contact
Caryn Mcdowell Global Biotech Executive - Public
View
Melita Sun Jung
View
Leanne Holes
Email
Karen Hodsdon
Email Phone

Employees by Management Level

Individual contributor 4 profiles
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 1
Legal 1 1 1

Terns Pharmaceuticals Tech Stack

Cloud / infrastructure 1 profile

Compare Similar Companies to Terns Pharmaceuticals